Drug Eluting Stent Intervention for Treating Side Branches Effectively

Phase 2

Active, not recruiting

• Conditions: Coronary artery disease; Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system

• Registration Number: ACTRN12606000259549
• Lead Sponsor: Devax, Inc

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-06-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Suitable candidate for percutaneous transluminal coronary angioplasty (PTCA) and/or stentingLesion matches Duke University angiographic criteria for a bifurcaiton.

Exclusion Criteria

Pregnant or women of childbearing potentialConcurrent MIDisease in more than two coronary arteriesRenal dysfunctionPrior stenting to target vesselUnable to comply with follow up procedure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified